A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088

Clinical trial NCT03610334 · COMPLETED

Trial details

NCT number: NCT03610334
Sponsor: InFlectis BioScience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2018-06-21
Primary completion: 2019-06-21
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.